Prendo (SymptoLab)

About

Q&A

What is Prendo (SymptoLab)'s primary focus?

Prendo (SymptoLab) is a digital health platform that helps women with hormone-related conditions track and predict symptom fluctuations over time.

When was Prendo (SymptoLab) founded?

Prendo (SymptoLab) was founded in 2024.

Where is Prendo (SymptoLab) headquartered?

Prendo (SymptoLab) is headquartered in New York City, United States.

Who are the co-founders of Prendo (SymptoLab)?

The co-founders of Prendo (SymptoLab) are Tamar Zelovich-Hod and Alon Zelovich, both appointed in 2025.

What technologies does Prendo (SymptoLab) utilize?

Prendo (SymptoLab) utilizes mathematical modeling, machine learning, and advanced analytics.

What types of customers does Prendo (SymptoLab) target?

Prendo (SymptoLab) targets patients, physicians, and health plans.

What is the role of Vered Klaitman-Meyer at Prendo (SymptoLab)?

Vered Klaitman-Meyer serves as the Medical Director of Gynecology at Prendo (SymptoLab).

What is the core technology behind Prendo (SymptoLab)'s platform?

The core technology behind Prendo (SymptoLab)'s platform is an AI-powered platform.

Team · 5

Tamar Zelovich-Hod

Founder · Co-founder

Alon Zelovich

Founder · Co-founder

Vered Klaitman-Meyer

Medical Director of Gynecology

Michael Lewis

Board Member

Noemie Elhadad

Advisory Board

Sectors & technology